Official UK procurement notice
DNA Repair Disorders Service
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionDNA nucleotide excision repair (DNA) disorders include xeroderma pigmentosa (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). Xeroderma Pigmentosa (XP) service was commissioned as a HSS in 2010, the service specification was updated in 2018 to include the CS and TTD. These are rare inherited multi-organ disorders and patients have specific, complex and specialist needs. Although the underlying diseases are not curable, there is potential to significantly improve health and quality of life through a comprehensive, expert patient focused service. Many individuals with CS/TTD require photoprotection, have reduced mobility or are on supplemental feeds.
The conditions are complex to diagnose and treat, and require input from: dermatology, dermatological surgery, paediatric neurology, adult neurology, ophthalmology, neuropsychology, clinical genetics, paediatric dentistry, psychology, dietetics, endocrinology, optometry, medical photography, audiology and palliative care.
CPV: Health and social work services
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 7 Nov 2024, 08:46 GMT
- Last source update
- 7 Nov 2024, 08:46 GMT
- FTS notice number
2024/S 000-036011- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04b484Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. Decision makers: National Commissioning Group (NCG) Tuesday 27th February 2024 AND Clinical Executive Group (CEG) Tuesday 12th March 2024 Conflicts of Interest identified among NCG and CEG: None
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Guy's and St Thomas' NHS Foundation Trust | £7,186,475 † | — | Awarded |
Contracts
Contract 036011-2024-1 · Guy's and St Thomas' NHS Foundation Trust
- Signed
- 5 Sept 2024
- Value
- £7,186,475
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Arden & Gem CSUReview body
Bidders & participating suppliers
1 commercial party on the notice- Guy's and St Thomas' NHS Foundation TrustAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.